By MediSafe
Report updated May 7, 2026
Medisafe Medication Management
For patients managing complex medication schedules and caregivers requiring coordinated health tracking.
Medisafe Medication Management is a struggling medical app that is free with in-app purchases. With a 4.7/5 rating from 99.6K reviews, it struggles with user retention. Users particularly appreciate reliable medication reminders provide essential daily support for managing complex health schedules, though frequent application crashes and interface freezes prevent users from logging medication doses remains a common concern.
What is Medisafe Medication Management?
Medisafe is a medication management app for patients and caregivers, providing pill reminders and health record integration on iOS.
Users hire Medisafe to manage complex medication regimens and ensure clinical safety, so the app must maintain high reliability to justify its utility.
Current Momentum
v9.50 · 2mo ago
Active- Shipped usability improvements to Manage section.
- Updated content in the updates section.
Active Nemesis
Pill Reminder MyTherapy
By smartpatient
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalRating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Automated alerts identifying potential conflicts between medications based on user input
Direct import of prescriptions from 100+ US hospitals via HealthKit
Real-time synchronization of medication schedules across family accounts
How much does it cost?
- Free tier with core reminders
- Premium subscription
Freemium model focused on high-volume acquisition to support B2B health partnerships.
Who Built It?
MediSafe
Providing digital medication management tools to improve patient adherence and support caregivers managing chronic conditions.
Portfolio
3
Apps
Who is MediSafe?
MediSafe Inc. has established a distinct position by bridging the gap between simple consumer pill reminders and complex health record integration. Their strategic advantage lies in clinical utility features, such as drug-to-drug interaction warnings and health record synchronization, which facilitate a B2B2C pathway through healthcare providers. Recent activity suggests a pivot toward specialized therapeutic support, expanding from a general adherence platform into niche condition-specific monitoring tools.
Who is MediSafe for?
- Patients managing complex medication regimens
- Chronic illnesses
- Caregivers requiring adherence oversight
Portfolio momentum
The publisher maintains an intense development cycle with 11 updates across 3 active apps in the last 6 months, ensuring high feature reliability.
What other apps does MediSafe make?
What do users think recently?
High confidence · 49 reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a upset sentiment. Users appreciate reliable medication reminders provide essential daily support for managing complex health schedules, but report frequent application crashes and interface freezes prevent users from logging medication doses and aggressive transition to a paid subscription model locks users out of existing data.
Limited review volume (49 reviews). Sentiment analysis will deepen as more data lands.
What is the competitive landscape for Medisafe Medication Management?
How's The Medical Market?
How does it evolve in the Medical market?
Medisafe holds the #75 Grossing and #100 Free rank in the US Medical category. The discrepancy between its high utility and declining sentiment suggests monetization friction is eroding its market position.
| Country | Category | Chart | Rank | Change |
|---|---|---|---|---|
| 🇩🇿 Algeria | Medical | iOSFree | #75 | NEW |
| 🇸🇳 Senegal | Medical | iOSGrossing | #88 |
The rivals identified
The Nemesis
Head to Head
The target app must leverage its clinical data integrations to differentiate from MyTherapy's pure-play adherence model, which appeals to users seeking a simpler, non-commercial experience.
What sets Medisafe Medication Management apart
Integrates directly with US Health Records for seamless medication list imports from over 100 hospital systems.
Provides advanced drug-to-drug interaction warnings that go beyond simple adherence tracking into clinical safety territory.
What's Pill Reminder MyTherapy's Edge
Maintains a neutral, non-commercial platform that avoids the pharmacy-centric retail focus of the target application.
Delivers a more streamlined user experience by stripping away the complex insurance and pharmacy management workflows.
Contenders
Provides real-time price comparison across local pharmacies, creating a strong utility-based retention loop for users.
Leverages a massive network effect of pharmacy pricing data that is difficult for pure adherence apps to replicate.
NimbleRx
★4.9 (98.1K)NimbleRx
⚡Represents a high-velocity threat with 26 releases in six months, focusing on the end-to-end pharmacy fulfillment experience.
Integrates direct prescription delivery services, shifting the user journey from simple reminders to active pharmacy fulfillment.
Maintains a high release cadence, allowing for rapid iteration on the pharmacy-to-doorstep user experience.
Peers
Locked-in user base through employer-sponsored pharmacy benefit plans, creating a structural barrier to entry for independent apps.
Provides direct access to insurance coverage details and mail-order pharmacy services within the primary app interface.
mySugr - Diabetes Tracker Log
★4.5 (134.1K)mySugr GmbH
⚡Adjacent sub-genre focusing on chronic condition management with a strong emphasis on data logging and health tracking.
Specializes in blood glucose logging and insulin tracking, creating a niche for diabetic users needing specialized tools.
Gamifies the health tracking experience to improve long-term user engagement and daily logging consistency.
The outtake for Medisafe Medication Management
Strengths to defend, gaps to attack
Core Strengths
- Clinical-grade drug interaction engine
- Deep integration with US health infrastructure
- Multi-user family sync
Critical Frictions
- High crash frequency post-update
- Mandatory paywall for historical data
- Inconsistent notification reliability
Growth Levers
- Expansion into chronic condition management
- B2B partnerships with pharmacy chains
Market Threats
- MyTherapy's non-commercial positioning
- GoodRx's dominance in pharmacy savings
- Rising churn from subscription friction
What are the next best moves?
Rebuild home screen stability because crashes are the #1 complaint → restore daily active habit
High-frequency crash reports prevent users from logging doses, which is the core utility.
Trade-off: Pause the premium-tier feature rollout — stability is the immediate retention priority.
Unlock historical data for free users because paywalling history is the #1 churn driver → reduce churn
User sentiment analysis shows mandatory payment for history is a primary complaint.
Trade-off: Deprioritize new UI polish in the Manage section — user retention outweighs cosmetic updates.
A counter-intuitive read
Medisafe's #75 Grossing rank is a liability, as it signals that the app is prioritizing short-term conversion over the stability required to maintain its category lead.
Feature Gaps vs Competitors
- Non-commercial adherence interface (available in MyTherapy but missing here)
Key Takeaways
Medisafe wins through clinical safety features, but the aggressive subscription paywall is driving churn, so the PM must prioritize stability and restore free access to historical data to defend the user base.
Where Is It Heading?
Declining
The medical adherence market is consolidating around non-commercial, utility-focused tools. Medisafe's current trajectory is exposed: if the team does not address stability and subscription friction, rivals like MyTherapy will continue to capture the churned user base.
Persistent application crashes prevent users from logging doses, which erodes the daily habit and drives long-term churn.
Mandatory subscription paywalls for historical data trigger user frustration, accelerating the shift to non-commercial adherence rivals.